Beckman Coulter

From Wikipedia, the free encyclopedia

  (Redirected from Beckman Instruments)
Jump to: navigation, search
Beckman Coulter, Inc.
Type Public (NYSE: BEC)
Founded Pasadena, California (1935, as National Technical Laboratories)
Headquarters Fullerton, California
Key people Scott Garrett, President and CEO
Charlie Slacik, SVP/CFO
Russ Bell, SVP
Bob Kleinert, EVP
Industry Biotechnology
Products Biomek platforms, Synchron analyzers, Immage Immunochemistry system, Hemoccult, CEQ 2000 DNA Analysis System, Flow cytometers
Revenue $2.761 billion USD (2007)
Employees 10,595 (2007)
Website www.beckmancoulter.com
A large laboratory centrifuge from Beckman.

Beckman Coulter Inc., is a company that makes biomedical laboratory instruments. Founded by Caltech professor Arnold O. Beckman in 1935 as National Technical Laboratories to commercialize a pH meter that he had invented, the company eventually grew to employ over 10,000 people, with $2.4 billion in annual sales by 2004. Its current headquarters are in Brea, California.

In the 1940s, Beckman changed the name to Arnold O. Beckman, Inc. to sell oxygen analyzers, the Helipot precision potentiometer, and spectrophotometers. In the 1950s, the company name changed to Beckman Instruments, Inc..

In 1955, Beckman established the seminal Shockley Semiconductor Laboratory as a division of Beckman Instruments to begin commercializing the semiconductor transistor technology invented by Caltech alumnus William Shockley. Because Shockley's aging mother lived in Palo Alto, California, the Shockley Laboratory was established in nearby Mountain View, California, and thus, "Silicon Valley" was born.

In 1982, the company merged into SmithKline to form SmithKline Beckman, with Arnold Beckman as vice chairman, but regained its independence in 1989 after SmithKline merged with Beecham Group to form SmithKline Beecham (now part of GlaxoSmithKline).

In 1995, the company acquired Hybritech, Inc. from Eli Lily

In 1996, the company acquired the Sanofi portion of Sanofi Pasteur Diagnostics

In 1998, the company acquired Coulter Corporation, a company founded by Wallace H. Coulter and changed its name to what it is today.

In 2005, the company acquired Diagnostic Systems Laboratories (DSL) based in Webster, Texas.

In 2006, the company acquired Lumigen and Agencourt Bioscience.

In 2007, the company acquired the Flow Cytometry Business Group of Dako North America, Inc.

In 2009, the company acquired Lab-based Diagnostics business of Olympus Japan.

In 2009, the company moved its world headquarters from Fullerton to the newly renovated facility in Brea, CA.

Contents

[edit] Executive management

  • CEO - Scott Garrett
  • CFO - Charlie Slacik
  • Executive VP Worldwide Commercial Operations - Robert Kleinert
  • Senior VP Quality and Regulatory - Melina Cimler
  • Senior VP General Counsel - Arnold Pinkston
  • Senior VP HR - Robert Hurley
  • Senior VP SCM - Pamela Miller
  • Senior VP - Russ Bell
  • Senior VP Strategy, Business Development & Investor Relations & Communications - Paul Glyer
  • Group VP Cellular - Cynthia Collins
  • Group VP High Sensitivity Testing Group - Mike Whelan
  • Group VP High Sensitivity Testing Group - Richard Creager
  • Group VP Chemistry, Discovery and Automation Business Group - Scott Atkin
  • VP Medical Director - Peter Heseltine

[edit] See also

[edit] References

[edit] External links


Languages